# Zoundream

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/zoundream

- Industry: Consumer Products
- Headquarters: Basel, Switzerland
- Website: www.zoundream.com/
- Total disclosed funding: $4.7M
- Latest round: Seed (Oct 3, 2025)
- Investors on record: 7

## About

Based in Switzerland, Zoundream AG specializes in innovative Cry Analysis technology that monitors infants' health through AI-driven sound recognition, aiming to support early detection of developmental disorders. Zoundream AG, founded in Basel, Switzerland in 2019 co-founded by Roberto Iannone (CEO) and Matteo Ingravalle (CTO), the company develops systems that monitor infant health. The company has successfully raised EUR 4 million in Seed funding, led by CRB Inverbio, with participation from various investors. The latest funding round occurred on October 3, 2025, and the total amount raised to date is EUR 4 million. Zoundream's core product offerings revolve around its advanced Cry Analysis technology, a comprehensive system for continuous, non-invasive monitoring of infants' health at home. Utilizing artificial intelligence and sound recognition, it analyzes baby cries to detect potential neurodevelopmental disorders, targeting parents and pediatricians to provide insights into infants' needs and health conditions. Extensive research within international clinical sites highlights its global market presence, particularly in Europe and North America, where demand for innovative infant care solutions is significant. Zoundream's revenue generation model is based on the sale of its Cry Analysis technology, potentially through direct-to-consumer channels and partnerships with healthcare providers. This includes subscription services for ongoing software updates and additional features, enhancing infant health monitoring. Specific pricing plans and transaction structures have not been disclosed. In October 2025, Zoundream AG raised EUR 4 million in Seed funding to accelerate product innovation, expand its global reach, and enhance outreach to families and healthcare professionals. The company is focused on designing new products and plans to enter new markets, although specific release dates and geographic targets have not been detailed.

## Funding rounds

- Seed, Oct 3, 2025, $4.7M — CRB Inverbio, Granatus Ventures, TQ Ventures, Verge HealthTech, Mission Gate, House of Insurtech Limited, Secways Ventures

## Investors

- CRB Inverbio — Seed
- Granatus Ventures (https://capitalatlas.ai/funds/granatus-ventures) — Seed
- TQ Ventures (https://capitalatlas.ai/funds/tq-ventures) — Seed
- Verge HealthTech (https://capitalatlas.ai/funds/verge-healthtech) — Seed
- Mission Gate (https://capitalatlas.ai/funds/mission-gate) — Seed
- House of Insurtech Limited — Seed
- Secways Ventures — Seed